Clinical Trials on Ocular Surface Microbiome in United States
Total 2570 results
-
Novartis PharmaceuticalsCompletedDiabetic Retinopathy | Macular OedemaUnited Kingdom
-
Apellis Pharmaceuticals, Inc.Active, not recruitingGeographic Atrophy Secondary to Age-related Macular DegenerationUnited States, Netherlands, France, Israel, Germany, United Kingdom, Canada, Czechia, Australia, Spain, Italy, Argentina, Brazil, New Zealand, Poland
-
Glendale Adventist Medical Center d/b/a Adventist...Helen Rey Breast Cancer Research Foundation; California Oncology Research Institute and other collaboratorsRecruitingDuctal Carcinoma in SituUnited States
-
Larkin Community HospitalWithdrawn
-
NYU Langone HealthTerminatedDuctal Carcinoma in SituUnited States
-
Shields, Shields and AssociatesUnknownUveal Melanoma | Radiation Retinopathy | Radiation MaculopathyUnited States
-
Alexion Pharmaceuticals, Inc.Active, not recruitingGeographic AtrophyUnited States, France, Germany, Italy, Spain, Korea, Republic of, United Kingdom, Canada, Japan, Czechia, Australia, Latvia, Hungary, Slovakia
-
Ocuphire Pharma, Inc.CompletedDiabetic Retinopathy | Diabetic Macular Edema | NPDR - Non Proliferative Diabetic Retinopathy | PDR - Proliferative Diabetic RetinopathyUnited States
-
Novartis PharmaceuticalsActive, not recruitingProgressive Supranuclear Palsy (PSP)Germany, United Kingdom, Canada, United States
-
Unity Biotechnology, Inc.RecruitingEye Diseases | Diabetes Mellitus | Retinal Degeneration | Retinal Diseases | Edema | Diabetic Retinopathy | Diabetic Macular Edema | Macular Edema | Retinal DiseaseUnited States
-
AllerganCompletedMacular DegenerationKorea, Republic of, Australia, Portugal, Germany, United States, Philippines, Italy
-
Jaeb Center for Health ResearchNational Eye Institute (NEI)CompletedDiabetic Retinopathy | Diabetic Macular EdemaUnited States
-
Jaeb Center for Health ResearchNational Eye Institute (NEI); Genentech, Inc.; AllerganCompletedDiabetic Retinopathy | Diabetic Macular EdemaUnited States
-
University of Texas Southwestern Medical CenterRecruitingParkinson Disease | Multiple System Atrophy | Progressive Supranuclear PalsyUnited States
-
Boehringer IngelheimTerminatedMacular DegenerationUnited Kingdom, United States
-
AllerganTerminatedAge-Related Maculopathy | Subfoveal Choroidal NeovascularizationUnited States
-
AllerganCompletedMacular Edema | Retinal Vein OcclusionFrance, United Kingdom, Spain, Israel, Germany, Italy
-
Imperial College LondonChelsea and Westminster NHS Foundation Trust; National Heart and Lung Institute and other collaboratorsCompletedNecrotizing Enterocolitis | Premature Intestinal Microbiota | Late Onset Bloodstream InfectionUnited Kingdom
-
Hoffmann-La RocheTerminatedGeographic AtrophyCanada, United States, Belgium, Peru, Argentina, Australia, Austria, Denmark, France, Germany, Hungary, Italy, Mexico, Netherlands, Poland, Slovakia, Spain, Switzerland, United Kingdom
-
Taiwan Liposome CompanyCompletedRetinal Vein Occlusion | Macula EdemaUnited States
-
Finn, Olivera, PhDBreast Cancer Research Foundation; A Glimmer of Hope FoundationRecruitingDuctal Carcinoma in SituUnited States
-
University of ChicagoTerminatedDuctal Carcinoma in SituUnited States
-
Novartis PharmaceuticalsCompletedDiabetic Macular EdemaUnited States, Hungary, Israel, Slovakia, Puerto Rico
-
National Eye Institute (NEI)CompletedMacular DegenerationUnited States
-
Massachusetts General HospitalDana-Farber Cancer Institute; Beth Israel Deaconess Medical Center; Brigham and... and other collaboratorsCompletedDuctal Breast CancerUnited States
-
Dana-Farber Cancer InstituteGE HealthcareTerminatedAtypical Ductal HyperplasiaUnited States
-
University of PennsylvaniaCompletedBreast Cancer | Breast Neoplasm | Carcinoma, Ductal | Cancer of the BreastUnited States
-
Eli Lilly and CompanyCompletedBreast Cancer | Breast Neoplasms, Male | Carcinoma, DuctalUnited States
-
Genentech, Inc.TerminatedGeographic Atrophy | Macular Degeneration, Age-RelatedUnited States
-
Hoffmann-La RocheCompletedMacular Degeneration, Age-Related | Neovascularization, ChoroidalUnited States
-
Hoffmann-La RocheTerminatedGeographic AtrophyUnited States, United Kingdom, Netherlands, Germany, Belgium, Poland, Spain, Argentina, Australia, Hungary, Italy, Portugal, France, Turkey, Austria, Russian Federation, Mexico, Peru, Denmark, Slovakia, Sweden, Switzerland
-
National Eye Institute (NEI)RecruitingRetinal Degeneration | Stargardt Disease | ABCA4 Retinopathy | Retinal DystrophyUnited States
-
University of LouisvilleNational Institute on Aging (NIA)CompletedProgressive Supranuclear PalsyUnited States, Canada
-
Apellis Pharmaceuticals, Inc.CompletedGeographic AtrophyItaly, Germany, United States, Israel, United Kingdom, France, Canada, Czechia, Australia, Spain, Argentina, New Zealand, Poland, Brazil, Puerto Rico
-
Steba Biotech S.A.TerminatedMacular Degeneration | Choroidal NeovascularizationUnited States, France
-
GlaxoSmithKlineCompleted
-
Fovea Pharmaceuticals SACompletedDiabetic Macular EdemaUnited States, Australia, Belgium, Czech Republic, France, Germany, Israel, Italy, Poland, Spain
-
Loma Linda UniversityH. Lundbeck A/SWithdrawnParkinson Disease | Multiple System Atrophy | Progressive Supranuclear PalsyUnited States
-
Royal Marsden NHS Foundation TrustPfizer; Breast Cancer NowActive, not recruitingGastric Cancer | Triple Negative Breast Cancer | Lobular Breast Carcinoma | CDH1 Gene MutationUnited Kingdom
-
Duke UniversityNational Cancer Institute (NCI)CompletedDuctal Carcinoma in SituUnited States
-
Novartis PharmaceuticalsCompletedDiabetic Macular EdemaUnited States, Austria, Japan, Australia, Spain, Canada, Israel, Netherlands, Italy, United Kingdom, Portugal, Colombia, Puerto Rico, Argentina
-
Noscira SAi3 ResearchCompletedProgressive Supranuclear PalsyUnited States, Germany, Spain, United Kingdom
-
Genentech, Inc.Completed
-
Yale UniversityCompletedDuctal Carcinoma in SituUnited States
-
Janssen Research & Development, LLCCompletedMacular Degeneration | Geographic Atrophy | Visual AcuityUnited States
-
PfizerCompletedDiabetic Retinopathy | Diabetic Macular Edema | Anti- VGF InhibitorSpain, United Kingdom, Finland, Sweden
-
BiogenTerminatedSupranuclear Palsy, ProgressiveUnited States
-
BiogenCompletedProgressive Supranuclear PalsyUnited States
-
Neurotech PharmaceuticalsCompletedA Study to Determine the Safety and Efficacy of NT-501 in Macular Telangiectasia Type 2 - Protocol AMacular Telangiectasia Type 2United States, United Kingdom, Australia, France
-
OPKO Health, Inc.CompletedMacular DegenerationUnited States